StockData
Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG) stock

DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025Score 5/30
$20.76+0.25 (+1.22%)

Close on Nov 18, 2026Market cap $158.52MP/E –Yield –

Bright Minds Biosciences EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2024 it was -0.65 CAD. The highest annual figure on record is -0.65 CAD in fiscal 2020.

Annual eps

PeriodPeriod endValueChange
FY2024Sep 30, 2024-0.65 CAD–
FY2023Sep 30, 2023-1.98 CAD–
FY2022Sep 30, 2022-6.06 CAD–
FY2021Sep 30, 2021-4.82 CAD–
FY2020Sep 30, 2020-0.65 CAD–

More Bright Minds Biosciences figures

See a number that looks wrong?